On Air Now

Current Show

Under the Hood   10:00 AM - 12:00 PM

Call Under the Hood with your questions at 866-594-4150

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 590 AM Kalamazoo, MI

Weather

Current Conditions(Kalamazoo,MI 49001)

More Weather »
79° Feels Like: 82°
Wind: E 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Few Showers 85°

Tonight

Partly Cloudy 65°

Tomorrow

Partly Cloudy 85°

Alerts

Merck's ragweed pollen allergy drug gets U.S. approval

(Reuters) - The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek.

The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis. (http://r.reuters.com/nyg68v)

The approval for Ragwitek comes days after U.S. regulatory approval for Merck's grass pollen allergy drug Grastek.

Merck's Grastek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.

(This story corrects fourth paragraph to say Grastek, not Ragwitek, will compete with Stallergenes' drug)

(Reporting by Shailesh Kuber; Editing by Sriraj Kalluvila)

Comments